Literature DB >> 15004322

Frontotemporal mild cognitive impairment.

Alexandre de Mendonça1, Filipa Ribeiro, Manuela Guerreiro, Carlos Garcia.   

Abstract

Mild Cognitive Impairment appears to be a heterogeneous clinical entity comprising patients in the initial phases of distinct neurological disorders. Since frontotemporal dementia (FTD) is a relatively common neurodegenerative disease with an insidious onset, it might be possible to detect the patients in the initial phases of the disorder, before being demented. In the present work we proposed a set of criteria to identify patients with mild cognitive impairment of the frontotemporal type (FT-MCI), applied these criteria retrospectively to a large patient database, and evaluated the progression of the patients. Seven subjects fulfilling the proposed criteria for frontotemporal MCI were identified. They had symptoms of apathy, disinhibition, irritability and aggressiveness, untidiness, difficulties in decision making, obsessions and lack of concern for the others, for 1.5 +/- 0.8 years before the diagnosis of FT-MCI. Brain CT or MRI scan displayed fronto-temporal atrophy in five. Neuropsychological examination revealed deficits in tests dependent upon the frontal lobe, namely attention, verbal, motor and graphomotor initiatives and conceptual thinking. The patients kept their professional and daily activities, and were not demented. It was possible to have the follow-up of all patients. All but one patient diagnosed FT-MCI developed dementia of the frontotemporal type within 1.8 +/- 1.0 years. Application of the proposed criteria for FT-MCI, at least in this clinical neurological setting, can identify a group of patients with a high probability of further cognitive decline to dementia of the frontotemporal type.

Entities:  

Mesh:

Year:  2004        PMID: 15004322     DOI: 10.3233/jad-2004-6101

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

1.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Authors:  Zahinoor Ismail; Eric E Smith; Yonas Geda; David Sultzer; Henry Brodaty; Gwenn Smith; Luis Agüera-Ortiz; Rob Sweet; David Miller; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2015-06-18       Impact factor: 21.566

2.  Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD.

Authors:  Silvia Morbelli; Michela Ferrara; Francesco Fiz; Barbara Dessi; Dario Arnaldi; Agnese Picco; Irene Bossert; Ambra Buschiazzo; Jennifer Accardo; Lorena Picori; Nicola Girtler; Paola Mandich; Marco Pagani; Gianmario Sambuceti; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-01       Impact factor: 9.236

3.  Discriminative and predictive power of an informant report in mild cognitive impairment.

Authors:  V Isella; L Villa; A Russo; R Regazzoni; C Ferrarese; I M Appollonio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

Review 4.  Premorbid de novo artistic creativity in frontotemporal dementia (FTD) syndromes.

Authors:  Felix Geser; Tibor C G Mitrovics; Johannes Haybaeck; Deniz Yilmazer-Hanke
Journal:  J Neural Transm (Vienna)       Date:  2021-10-07       Impact factor: 3.575

Review 5.  Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease.

Authors:  Gregory A Jicha; Sarah A Carr
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Mild cognitive impairment: historical development and summary of research.

Authors:  James Golomb; Alan Kluger; Steven H Ferris
Journal:  Dialogues Clin Neurosci       Date:  2004-12       Impact factor: 5.986

7.  Validation of the Dutch version of the quick mild cognitive impairment screen (Qmci-D).

Authors:  Steven Bunt; Rónán O'Caoimh; Wim P Krijnen; D William Molloy; Geert Pieter Goodijk; Cees P van der Schans; Hans J S M Hobbelen
Journal:  BMC Geriatr       Date:  2015-10-02       Impact factor: 3.921

8.  Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals.

Authors:  Alessandro Martorana; Francesco Di Lorenzo; Guglielmo Manenti; Roberta Semprini; Giacomo Koch
Journal:  Front Aging Neurosci       Date:  2014-09-23       Impact factor: 5.750

9.  Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.

Authors:  Rónán O'Caoimh; Suzanne Timmons; D William Molloy
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

10.  False Memory and Alzheimer's Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with Amyloid PET.

Authors:  Eun-Ji Choi; Bum Joon Kim; Hyung-Ji Kim; Miseon Kwon; Noh Eul Han; Sun-Mi Lee; Sungyang Jo; Sunju Lee; Jae-Hong Lee
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.